Brief: Day One Biopharmaceuticals Inc Reports Quarterly Loss Per Share Of $0.53

Day One Biopharmaceuticals

07/11/2022 22:02

Nov 7 (Reuters) - Day One Biopharmaceuticals Inc
 DAWN.O :
    * DAY ONE REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND
CORPORATE PROGRESS
    * DAY ONE BIOPHARMACEUTICALS INC - BASED ON CURRENT
OPERATING
PLAN, MANAGEMENT BELIEVES IT HAS SUFFICIENT CAPITAL RESOURCES TO
FUND ANTICIPATED OPERATIONS INTO 2025
    * DAY ONE BIOPHARMACEUTICALS INC - QTRLY LOSS PER SHARE
$0.53

Source text for Eikon:  ID:nGNX4qJHBd 
Further company coverage:  DAWN.O 
 ((Reuters.Briefs@thomsonreuters.com;;))